down arrow

Zydus Wellness

  • Market Cap: Mid Cap
  • Industry: FMCG
  • ISIN: INE768C01010
  • NSEID: ZYDUSWELL
  • BSEID: 531335
INR
1,750.80
12.8 (0.74%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 25.25 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,720.701,780.10

52 Week

1,493.002,484.00
Valuation
Technical
Day's Volume

CASH

25.25 k (3.51%) Volume

Shareholding (Dec 2024)

FII

3.37%

Held by 99 FIIs

DII

20.12%

Held by 15 DIIs

Promoter

69.62%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 8.75% and Operating profit at 6.64% over the last 5 years

 
2

Flat results in Dec 24

3

Stock is technically in a Mildly Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

FMCG

stock-summary
Market cap

INR 11,141 Cr (Mid Cap)

stock-summary
P/E

35.00

stock-summary
Industry P/E

54

stock-summary
Dividend Yield

0.29%

stock-summary
Debt Equity

-0.04

stock-summary
Return on Equity

5.72%

stock-summary
Price to Book

2.01

Revenue and Profits (1 Year):
Net Sales:
462 Cr
(Quarterly Results - Dec 2024)
Net Profit:
6 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.29%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-10.75%
0%
-10.75%
1 Year
9.71%
0.30%
10.01%
2 Years
15.0%
0.66%
15.66%
3 Years
6.25%
0.98%
7.23%
4 Years
-16.53%
0.94%
-15.59%
5 Years
19.9%
1.61%
21.51%

Latest dividend: 5 per share ex-dividend date: Jul-19-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.75%
EBIT Growth (5y)
6.64%
EBIT to Interest (avg)
13.56
Debt to EBITDA (avg)
1.75
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.39
Tax Ratio
4.27%
Dividend Payout Ratio
11.91%
Pledged Shares
0
Institutional Holding
23.49%
ROCE (avg)
6.04%
ROE (avg)
5.64%
Valuation key factors
Factor
Value
P/E Ratio
35
Industry P/E
54
Price to Book Value
2.01
EV to EBIT
32.71
EV to EBITDA
30.76
EV to Capital Employed
2.06
EV to Sales
4.20
PEG Ratio
2.66
Dividend Yield
0.29%
ROCE (Latest)
6.24%
ROE (Latest)
5.71%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 14 Schemes (11.87%)

FIIs

Held by 99 FIIs (3.37%)

Promoter with highest holding

Zydus Lifesciences Limited (57.59%)

Highest Public shareholder

Threpsi Care Llp (7.27%)

Individual Investors Holdings

5.56%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -6.29% vs -41.39% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -69.38% vs -85.85% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "461.90",
          "val2": "492.90",
          "chgp": "-6.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.80",
          "val2": "19.60",
          "chgp": "-24.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.30",
          "val2": "0.90",
          "chgp": "266.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "5.90",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.40",
          "val2": "20.90",
          "chgp": "-69.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.28%",
          "val2": "3.99%",
          "chgp": "-0.71%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 16.80% vs 1.47% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 44.97% vs -20.07% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,333.90",
          "val2": "1,142.00",
          "chgp": "16.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "174.80",
          "val2": "133.30",
          "chgp": "31.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.50",
          "val2": "11.60",
          "chgp": "-61.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.90",
          "val2": "-14.20",
          "chgp": "141.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "168.60",
          "val2": "116.30",
          "chgp": "44.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.14%",
          "val2": "11.72%",
          "chgp": "1.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 16.22% vs 0.21% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 50.09% vs -29.38% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,795.80",
          "val2": "1,545.20",
          "chgp": "16.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "189.60",
          "val2": "146.00",
          "chgp": "29.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.80",
          "val2": "17.90",
          "chgp": "-56.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.90",
          "val2": "-14.20",
          "chgp": "141.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "175.00",
          "val2": "116.60",
          "chgp": "50.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.56%",
          "val2": "9.45%",
          "chgp": "1.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 3.24% vs 12.23% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -14.01% vs 0.50% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,327.80",
          "val2": "2,254.80",
          "chgp": "3.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "308.20",
          "val2": "337.20",
          "chgp": "-8.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "24.00",
          "val2": "16.10",
          "chgp": "49.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-14.20",
          "val2": "-10.10",
          "chgp": "-40.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "266.90",
          "val2": "310.40",
          "chgp": "-14.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.31%",
          "val2": "15.04%",
          "chgp": "-1.73%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
461.90
492.90
-6.29%
Operating Profit (PBDIT) excl Other Income
14.80
19.60
-24.49%
Interest
3.30
0.90
266.67%
Exceptional Items
0.00
5.90
-100.00%
Consolidate Net Profit
6.40
20.90
-69.38%
Operating Profit Margin (Excl OI)
3.28%
3.99%
-0.71%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -6.29% vs -41.39% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -69.38% vs -85.85% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1,333.90
1,142.00
16.80%
Operating Profit (PBDIT) excl Other Income
174.80
133.30
31.13%
Interest
4.50
11.60
-61.21%
Exceptional Items
5.90
-14.20
141.55%
Consolidate Net Profit
168.60
116.30
44.97%
Operating Profit Margin (Excl OI)
13.14%
11.72%
1.42%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 16.80% vs 1.47% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 44.97% vs -20.07% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,795.80
1,545.20
16.22%
Operating Profit (PBDIT) excl Other Income
189.60
146.00
29.86%
Interest
7.80
17.90
-56.42%
Exceptional Items
5.90
-14.20
141.55%
Consolidate Net Profit
175.00
116.60
50.09%
Operating Profit Margin (Excl OI)
10.56%
9.45%
1.11%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 16.22% vs 0.21% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 50.09% vs -29.38% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
2,327.80
2,254.80
3.24%
Operating Profit (PBDIT) excl Other Income
308.20
337.20
-8.60%
Interest
24.00
16.10
49.07%
Exceptional Items
-14.20
-10.10
-40.59%
Consolidate Net Profit
266.90
310.40
-14.01%
Operating Profit Margin (Excl OI)
13.31%
15.04%
-1.73%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 3.24% vs 12.23% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -14.01% vs 0.50% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Zydus Wellness Ltd stock-summary
stock-summary
Zydus Wellness Ltd
Mid Cap
FMCG
Headquartered in Ahmedabad, Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The Company's product portfolio includes popular brands with functional benefits like Glucon D, Complan, Sugar Free, Nycil, Everyuth, Nutralite and Sugarlite.
Company Coordinates stock-summary
Company Details
Zydus Corporate Park S No 536, Sarkhej-Gandhinagar Highway Ahmedabad Gujarat : 382481
stock-summary
Tel: 91-79-67775888
stock-summary
http://www.zyduswellness.in
stock-summary
investor.grievance@zyduswellness.in
Registrar Details
Link Intime India Pvt Ltd., UnitNo. 303, 3rd Floor, Shoppers Plaza V, Opp. Municipal Market, B/h. Shoppers Plaza II, Off. C. G. Road,, Ahmedabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."